Stoughton, MA, United States of America

Brandon D Cash

USPTO Granted Patents = 10 

 

 

Average Co-Inventor Count = 13.2

ph-index = 2

Forward Citations = 25(Granted Patents)


Location History:

  • Framingham, MA (US) (2015 - 2017)
  • Stoughton, MA (US) (2019 - 2023)

Company Filing History:


Years Active: 2015-2025

Loading Chart...
Loading Chart...
Loading Chart...
10 patents (USPTO):

Title: The Innovations of Brandon D. Cash: A Trailblazer in STING Agonists

Introduction: Brandon D. Cash, based in Stoughton, MA, is a prominent inventor with an impressive portfolio, holding a total of 9 patents. His groundbreaking work primarily focuses on the development of compounds as STING agonists, which play a crucial role in immune response and cancer treatment.

Latest Patents: Among his most recent patents, Brandon D. Cash has developed Aza-benzothiophene compounds as STING agonists. These compounds, represented by a specific general formula and their pharmaceutically acceptable salts, are designed to induce type I interferon production, functioning specifically as STING active agents. The provided compositions and synthesis processes are aimed at utilizing these compounds for medical purposes, including treating cell proliferation disorders such as cancer. He has also created a range of STING agonist compounds, with similar applications and properties, reinforcing his commitment to advancing innovative therapies in immunology.

Career Highlights: Brandon D. Cash has made significant contributions while working at well-known organizations such as Merck Sharp & Dohme Corporation and Merck Canada Inc. These companies have provided him with the platform to develop and refine his innovative concepts in the field of pharmacology and biotechnology.

Collaborations: Throughout his career, Brandon has collaborated with esteemed colleagues including Michael D. Altman and Ryan D. Otte. These partnerships have been instrumental in fostering creativity and enhancing the scope of his research endeavors.

Conclusion: Brandon D. Cash stands out as a leading inventor whose work on STING agonists has the potential to transform treatment paradigms for various diseases, particularly in oncology and immunotherapy. His dedication to innovation and collaboration continues to drive advancements in the scientific community, establishing him as a key figure in the development of novel therapeutic agents.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…